Ignite Creation Date:
2024-05-06 @ 1:59 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01943864
Status:
COMPLETED
Last Update Posted:
2017-05-31
First Post:
2013-09-12
Brief Title:
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-19
Start Date Type:
None
Primary Completion Date:
2014-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-12
First Submit QC Date:
September 12 2013
Study First Post Date:
2013-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-03-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-03
Last Update Post Date:
2017-05-31
Last Update Post Date Type:
ACTUAL